Tiziana Life Sciences LTD
Nasdaq TLSA · London, England, United Kingdom
Works in GI & liver · Immunology · Infectious disease · Metabolic & endocrine · Neurology · Oncology · Respiratory
Tiziana Life Sciences LTD is a clinical trial sponsor based in London, England, United Kingdom, listed as Nasdaq TLSA. It has 4 active clinical trials with 158 planned participants, across 7 therapeutic areas. Since 2021 it has completed 2 trials and stopped 3 early.
Trial track record · since 2021
Financials · Nasdaq TLSA
Fundraising
Pipeline · 4 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Tiziana Life Sciences LTD
Tiziana Life Sciences LTD is lead sponsor of 4 active clinical trials on ClinicalTrials.gov, with 158 planned participants, in GI & liver, Immunology, Infectious disease, Metabolic & endocrine and other areas. Since 2021 it has completed 2 trials and stopped 3 early.
Tiziana Life Sciences LTD is based in London, England, United Kingdom and is listed as Nasdaq TLSA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Tiziana Life Sciences LTD; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-21.
Approve Suite is not affiliated with Tiziana Life Sciences LTD.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.